CN109692304A - The drug for treating hypercortisolism - Google Patents

The drug for treating hypercortisolism Download PDF

Info

Publication number
CN109692304A
CN109692304A CN201710989246.XA CN201710989246A CN109692304A CN 109692304 A CN109692304 A CN 109692304A CN 201710989246 A CN201710989246 A CN 201710989246A CN 109692304 A CN109692304 A CN 109692304A
Authority
CN
China
Prior art keywords
drug
hypercortisolism
treating
chinese
knotweed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710989246.XA
Other languages
Chinese (zh)
Inventor
焦雁琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710989246.XA priority Critical patent/CN109692304A/en
Publication of CN109692304A publication Critical patent/CN109692304A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483—Gleditsia (locust)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses a kind of drug for treating hypercortisolism, consists of the following compositions: Chinese mesona herb 10g-20g, erythrina bark 15g-30g, rhizoma curcumae longae concisa 5g-8g, Ramulus euonymi 5g-6g, vine of multiflower knotweed 12g-15g, Pine Nodular Branch 8g-10g, spina gleditsiae 3g-5g, Chinese knotweed 4g-9g, iron holly bark 16g-25g and smilax 1g-3g.The beneficial effects of the present invention are: hypercortisolism can be effectively treated, quick, crowd that is without side-effects and being suitable for each age group and different sexes.

Description

The drug for treating hypercortisolism
Technical field
The invention belongs to drug fields, and in particular to a kind of drug for treating hypercortisolism.
Background technique
Hypercortisolism is a kind of common, multiple and all age group, the symptom that men and women, old and young can occur.Currently, There is also the drugs of many treatment hypercortisolisms, but mostly the not so good and many drug of curative effect can generate it is certain Side effect.With the development of society, these drugs are no longer satisfied disease Man's Demands.
Summary of the invention
The technical problems to be solved by the invention are in view of the above shortcomings of the prior art, to provide and a kind of treat cortisol The drug of increase disease can easily treat hypercortisolism and without side-effects.
The technical scheme adopted by the invention is that: a kind of drug for treating hypercortisolism consists of the following compositions:
Chinese mesona herb 10g-20g, erythrina bark 15g-30g, rhizoma curcumae longae concisa 5g-8g, Ramulus euonymi 5g-6g, vine of multiflower knotweed 12g-15g, Pine Nodular Branch 8g-10g, spina gleditsiae 3g-5g, Chinese knotweed 4g-9g, iron holly bark 16g-25g and smilax 1g-3g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: hypercortisolism can be effectively treated, it is quick, it is without side-effects and be suitable for The crowd of each age group and different sexes.
Specific embodiment
Below in conjunction with specific embodiment, invention is further described in detail.
A kind of drug for treating hypercortisolism, consists of the following compositions:
Chinese mesona herb 10g-20g, erythrina bark 15g-30g, rhizoma curcumae longae concisa 5g-8g, Ramulus euonymi 5g-6g, vine of multiflower knotweed 12g-15g, Pine Nodular Branch 8g-10g, spina gleditsiae 3g-5g, Chinese knotweed 4g-9g, iron holly bark 16g-25g and smilax 1g-3g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: hypercortisolism can be effectively treated, it is quick, it is without side-effects and be suitable for The crowd of each age group and different sexes.

Claims (4)

1. a kind of drug for treating hypercortisolism, it is characterised in that: consist of the following compositions:
Chinese mesona herb 10g-20g, erythrina bark 15g-30g, rhizoma curcumae longae concisa 5g-8g, Ramulus euonymi 5g-6g, vine of multiflower knotweed 12g-15g, Pine Nodular Branch 8g-10g, spina gleditsiae 3g-5g, Chinese knotweed 4g-9g, iron holly bark 16g-25g and smilax 1g-3g.
2. a kind of drug for treating hypercortisolism according to claim 1, it is characterised in that: described drug can be made At decoction.
3. a kind of drug for treating hypercortisolism according to claim 1, it is characterised in that: described drug can be made At tablet.
4. a kind of drug for treating hypercortisolism according to claim 1, it is characterised in that: described drug can be made At capsule.
CN201710989246.XA 2017-10-22 2017-10-22 The drug for treating hypercortisolism Pending CN109692304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710989246.XA CN109692304A (en) 2017-10-22 2017-10-22 The drug for treating hypercortisolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710989246.XA CN109692304A (en) 2017-10-22 2017-10-22 The drug for treating hypercortisolism

Publications (1)

Publication Number Publication Date
CN109692304A true CN109692304A (en) 2019-04-30

Family

ID=66226574

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710989246.XA Pending CN109692304A (en) 2017-10-22 2017-10-22 The drug for treating hypercortisolism

Country Status (1)

Country Link
CN (1) CN109692304A (en)

Similar Documents

Publication Publication Date Title
CN109692304A (en) The drug for treating hypercortisolism
CN109419918A (en) A kind of drug for treating hemorrhoid
CN109419861A (en) A kind of drug for treating tympanitis
CN109692260A (en) A kind of drug for treating primary aldosteronism
CN104027692A (en) Traditional Chinese medicine preparation for treating beriberi
CN109692268A (en) The drug for treating multiple sclerosis
CN109692217A (en) The drug for treating leukopenia
CN109692275A (en) The drug for treating hyperthyroid heart disease
CN109419952A (en) A kind of drug for treating thrombocytopenic purpura
CN109692295A (en) The drug for treating cold
CN109692218A (en) The drug for treating chronic cor pulmonale
CN109692299A (en) A kind of drug for treating diabetes
CN109692297A (en) The drug for treating tinea of feet and hands
CN101879296A (en) Traditional Chinese medicine for treating lumbocrural pain
CN109692281A (en) A kind of drug for treating sphagitis
CN109692280A (en) A kind of drug for treating myasthenia gravis
CN109692246A (en) A kind of drug for treating motor neuron disease
CN109692287A (en) The drug for treating dermatitis
CN109692237A (en) The drug for treating coronary heart disease
CN109420056A (en) A kind of drug for treating toothache
CN109419873A (en) A kind of drug for treating gastrorrhagia
CN109692231A (en) The drug for treating chronic glomerulonephritis
CN109420102A (en) A kind of drug for treating gastritis
CN109692293A (en) The drug for treating cerebrovascular sclerosis
CN104940688A (en) Traditional Chinese medicine for treating prostatitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190430

WD01 Invention patent application deemed withdrawn after publication